Sun, H., Mediwala, S. N., Szafran, A. T., Mancini, M. A., & Marcelli, M. (2016). CUDC-101, a Novel Inhibitor of Full-Length Androgen Receptor (flAR) and Androgen Receptor Variant 7 (AR-V7) Activity: Mechanism of Action and In Vivo Efficacy. Horm Cancer.
Styl cytowania ChicagoSun, Huiying, Sanjay N. Mediwala, Adam T. Szafran, Michael A. Mancini, i Marco Marcelli. "CUDC-101, a Novel Inhibitor of Full-Length Androgen Receptor (flAR) and Androgen Receptor Variant 7 (AR-V7) Activity: Mechanism of Action and In Vivo Efficacy." Horm Cancer 2016.
Styl cytowania MLASun, Huiying, et al. "CUDC-101, a Novel Inhibitor of Full-Length Androgen Receptor (flAR) and Androgen Receptor Variant 7 (AR-V7) Activity: Mechanism of Action and In Vivo Efficacy." Horm Cancer 2016.